Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Benkert

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Blood Cells, Molecules & Diseases|July 5, 2022
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatmentLaura Infanti, Gerda Leitner, Morten K Moe, et al.
Diagnostic and Prognostic Research|October 28, 2021
Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosisKonstantina Chalkou, Ewout Steyerberg, Patrick Bossuyt, et al.
BMC Medical Research Methodology|February 15, 2017
Generating evidence on a risk-based monitoring approach in the academic setting - lessons learnedBelinda von Niederhäusern, Annette Orleth, Sabine Schädelin, et al.
Annals of Clinical and Translational Neurology|March 1, 2022
Development of an age-adjusted model for blood neurofilament light chainChristopher Harp, Gian-Andrea Thanei, Xiaoming Jia, et al.
BMC Medical Research Methodology|December 9, 2017
Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric populationBelinda von Niederhäusern, Ramon Saccilotto, Sabine Schädelin, et al.
Journal of the Peripheral Nervous System : JPNS|February 5, 2026
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis PolyneuropathyValentin Loser, Pascal Benkert, Alex Vicino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2020
Disability progression <i>in relapse-free</i> multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetateViktor von Wyl, Pascal Benkert, André Moser, et al.
World Journal of Gastroenterology|May 8, 2014
Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinomaFrank Serge Lehmann, Francesca Trapani, Ida Fueglistaler, et al.
Frontiers in Neurology|March 27, 2023
Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serumMarisol Herrera-Rivero, Edith Hofer, Aleksandra Maceski, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 25, 2025
Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assayRonald A Booth, Daniel Beriault, Raphael Schneider, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Blood Cells, Molecules & Diseases|July 5, 2022
Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatmentLaura Infanti, Gerda Leitner, Morten K Moe, et al.
Diagnostic and Prognostic Research|October 28, 2021
Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosisKonstantina Chalkou, Ewout Steyerberg, Patrick Bossuyt, et al.
BMC Medical Research Methodology|February 15, 2017
Generating evidence on a risk-based monitoring approach in the academic setting - lessons learnedBelinda von Niederhäusern, Annette Orleth, Sabine Schädelin, et al.
Annals of Clinical and Translational Neurology|March 1, 2022
Development of an age-adjusted model for blood neurofilament light chainChristopher Harp, Gian-Andrea Thanei, Xiaoming Jia, et al.
BMC Medical Research Methodology|December 9, 2017
Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric populationBelinda von Niederhäusern, Ramon Saccilotto, Sabine Schädelin, et al.
Journal of the Peripheral Nervous System : JPNS|February 5, 2026
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis PolyneuropathyValentin Loser, Pascal Benkert, Alex Vicino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2020
Disability progression <i>in relapse-free</i> multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetateViktor von Wyl, Pascal Benkert, André Moser, et al.
World Journal of Gastroenterology|May 8, 2014
Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinomaFrank Serge Lehmann, Francesca Trapani, Ida Fueglistaler, et al.
Frontiers in Neurology|March 27, 2023
Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serumMarisol Herrera-Rivero, Edith Hofer, Aleksandra Maceski, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 25, 2025
Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assayRonald A Booth, Daniel Beriault, Raphael Schneider, et al.
Pageof 14